This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 3B Pharmaceuticals Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eberhard Schneider: Innovator in Fibroblast Activation Protein Research
Introduction
Eberhard Schneider is a notable inventor based in Michendorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of fibroblast activation proteins. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing science.
Latest Patents
Eberhard Schneider holds a patent titled "Compounds Comprising a Fibroblast Activation Protein Ligand and Use Thereof." This patent reflects his research and development efforts in creating compounds that can potentially enhance therapeutic outcomes in medical treatments.
Career Highlights
Schneider is associated with 3B Pharmaceuticals GmbH, where he continues to work on groundbreaking research. His career is marked by a commitment to innovation and the pursuit of knowledge in the pharmaceutical industry.
Collaborations
Throughout his career, Eberhard Schneider has collaborated with esteemed colleagues such as Frank Osterkamp and Dirk Zboralski. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Eberhard Schneider's contributions to the field of pharmaceuticals, particularly through his patent and collaborations, highlight his role as an influential inventor. His work continues to inspire advancements in medical science and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile